bf/NYSE:TMO_icon.jpeg

NYSE:TMO

Thermo Fisher Scientific Inc.

  • Stock

USD

Last Close

595.30

20/05 20:00

Market Cap

211.47B

Beta: 0.79

Volume Today

630.25K

Avg: 1.25M

PE Ratio

35.85

PFCF: 32.57

Dividend Yield

0.25%

Payout:8.48%

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.47B
-
1.68B
14.17%
1.93B
14.82%
2.10B
9.19%
2.59B
23.29%
2.99B
15.27%
3.19B
6.68%
3.70B
16.06%
4.54B
22.72%
5.34B
17.68%
5.36B
0.35%
average payables
666.45M
-
756.10M
13.45%
821.45M
8.64%
874.20M
6.42%
1.18B
34.65%
1.52B
29.26%
1.77B
16.17%
2.05B
15.84%
2.52B
23.13%
3.12B
23.92%
3.13B
0.08%
average receivables
1.87B
-
2.21B
17.85%
2.51B
13.65%
2.80B
11.46%
3.46B
23.85%
4.01B
15.70%
4.24B
5.86%
5.04B
18.92%
6.86B
35.96%
8.13B
18.46%
8.82B
8.60%
book value per share
46.78
-
51.60
10.30%
53.55
3.77%
54.56
1.88%
64.34
17.92%
68.62
6.66%
74.19
8.11%
87.14
17.46%
85.13
2.31%
112.33
31.95%
120.42
7.21%
capex per share
-0.78
-
-1.07
37.00%
-1.06
1.22%
-1.13
6.12%
-1.29
14.25%
-1.89
46.61%
-2.31
22.77%
-3.72
60.79%
-6.40
72.04%
-5.72
10.64%
-3.81
33.38%
capex to depreciation
-0.28
-
-0.25
10.14%
-0.25
1.30%
-0.25
0.91%
-0.25
1.15%
-0.33
33.81%
-0.41
21.63%
-0.63
55.89%
-0.97
53.54%
-0.66
31.84%
-0.43
34.55%
capex to operating cash flow
-0.14
-
-0.16
16.22%
-0.15
8.03%
-0.14
6.22%
-0.13
9.91%
-0.17
31.54%
-0.19
11.60%
-0.18
4.50%
-0.26
48.67%
-0.25
7.32%
-0.18
28.19%
capex to revenue
-0.02
-
-0.03
17.36%
-0.02
1.54%
-0.02
2.44%
-0.02
0.14%
-0.03
28.14%
-0.04
16.50%
-0.05
26.20%
-0.06
40.64%
-0.05
22.39%
-0.03
30.90%
cash per share
16.18
-
3.40
79.02%
1.13
66.60%
1.99
75.62%
3.38
69.72%
5.23
54.79%
6.00
14.65%
26.07
334.74%
11.36
56.42%
21.74
91.37%
20.82
4.27%
days of inventory on hand
74.33
-
75.66
1.80%
82.77
9.40%
85.41
3.18%
98.93
15.84%
84.41
14.68%
89.69
6.25%
93.59
4.35%
97.15
3.80%
80.91
16.71%
67.21
16.94%
days payables outstanding
34.39
-
33.39
2.90%
34.17
2.33%
35.74
4.59%
47.55
33.05%
45.37
4.60%
51.10
12.64%
50.52
1.12%
55.14
9.14%
48.56
11.94%
37.94
21.87%
days sales outstanding
54.16
-
53.46
1.29%
54.75
2.42%
60.89
11.21%
67.69
11.16%
61.98
8.43%
62.15
0.28%
65.04
4.65%
74.25
14.17%
67.24
9.45%
70.02
4.13%
debt to assets
0.33
-
0.34
3.82%
0.31
10.55%
0.36
18.73%
0.37
2.34%
0.34
8.95%
0.31
9.75%
0.31
3.18%
0.37
16.87%
0.35
3.64%
0.35
0.23%
debt to equity
0.62
-
0.71
13.92%
0.59
17.22%
0.77
31.57%
0.83
7.08%
0.69
16.73%
0.60
13.10%
0.63
5.29%
1.04
65.05%
0.78
24.66%
0.75
4.59%
dividend yield
0.01
-
0.00
12.67%
0.00
9.61%
0.00
0.60%
0.00
26.16%
0.00
6.43%
0.00
22.70%
0.00
20.06%
0.00
17.76%
0.00
40.28%
0.00
20.48%
earnings yield
0.03
-
0.04
19.64%
0.03
8.01%
0.04
3.91%
0.03
18.26%
0.03
10.09%
0.03
12.91%
0.03
21.52%
0.03
14.98%
0.03
9.56%
0.03
9.58%
enterprise value
44.78B
-
63.11B
40.93%
68.63B
8.75%
71.55B
4.25%
94.68B
32.32%
106.85B
12.86%
145.30B
35.99%
195.86B
34.80%
293.29B
49.74%
241.83B
17.54%
232.79B
3.74%
enterprise value over ebitda
16.84
-
17.27
2.57%
16.52
4.37%
16.11
2.46%
18.38
14.08%
17.11
6.93%
21.98
28.50%
19.20
12.66%
24.11
25.57%
20.06
16.79%
21.71
8.21%
ev to operating cash flow
22.27
-
24.09
8.17%
24.36
1.13%
22.67
6.96%
23.64
4.28%
23.52
0.51%
29.22
24.23%
23.63
19.13%
30.73
30.07%
26.42
14.04%
27.69
4.82%
ev to sales
3.42
-
3.74
9.23%
4.05
8.26%
3.92
3.21%
4.53
15.60%
4.39
3.08%
5.69
29.68%
6.08
6.86%
7.48
23.04%
5.38
28.01%
5.43
0.88%
free cash flow per share
4.80
-
5.50
14.76%
6.00
9.08%
6.87
14.40%
8.85
28.88%
9.42
6.35%
10.12
7.46%
17.21
70.10%
17.82
3.53%
17.63
1.05%
17.85
1.26%
free cash flow yield
0.04
-
0.04
1.99%
0.04
3.66%
0.05
15.01%
0.05
4.23%
0.04
9.76%
0.03
25.98%
0.04
18.64%
0.03
27.73%
0.03
19.89%
0.03
5.06%
graham net net
-19.39
-
-45.09
132.56%
-40.75
9.61%
-50.96
25.04%
-64.42
26.42%
-54.45
15.48%
-52.92
2.80%
-45.20
14.59%
-207.32
358.66%
-90.80
56.20%
-90.46
0.38%
graham number
60.99
-
74.32
21.85%
77.26
3.96%
79.29
2.62%
90.30
13.89%
106.23
17.64%
124.19
16.91%
177.66
43.05%
193.79
9.08%
211.68
9.23%
204.61
3.34%
income quality
1.57
-
1.38
12.08%
1.42
2.93%
1.56
9.56%
1.80
15.34%
1.55
13.98%
1.35
12.98%
1.30
3.36%
1.23
5.03%
1.32
6.51%
1.40
6.61%
intangibles to total assets
0.61
-
0.77
25.85%
0.77
0.31%
0.77
0.05%
0.74
3.68%
0.72
3.23%
0.68
4.88%
0.56
17.86%
0.65
16.70%
0.60
7.91%
0.61
1.99%
interest coverage
6.14
-
5.22
15.07%
5.63
7.96%
5.22
7.37%
5.01
3.87%
5.67
13.13%
6.80
19.82%
14.09
107.39%
18.71
32.74%
11.56
38.21%
5.32
53.96%
interest debt per share
29.83
-
37.78
26.63%
32.46
14.08%
43.31
33.42%
54.68
26.27%
48.90
10.58%
46.07
5.78%
56.28
22.17%
89.86
59.66%
89.83
0.03%
93.54
4.12%
inventory turnover
4.91
-
4.82
1.76%
4.41
8.59%
4.27
3.08%
3.69
13.67%
4.32
17.21%
4.07
5.88%
3.90
4.17%
3.76
3.66%
4.51
20.07%
5.43
20.39%
invested capital
0.62
-
0.71
13.92%
0.59
17.22%
0.77
31.57%
0.83
7.08%
0.69
16.73%
0.60
13.10%
0.63
5.29%
1.04
65.05%
0.78
24.66%
0.75
4.59%
market cap
40.12B
-
49.89B
24.35%
56.56B
13.36%
55.71B
1.50%
75.00B
34.64%
89.96B
19.95%
129.95B
44.45%
184.45B
41.94%
262.89B
42.53%
215.87B
17.89%
205.95B
4.60%
net current asset value
-5.14B
-
-15.69B
205.50%
-13.95B
11.07%
-17.34B
24.30%
-21.74B
25.35%
-17.95B
17.41%
-16.65B
7.26%
-12.59B
24.41%
-74.60B
492.63%
-27.78B
62.77%
-27.30B
1.74%
net debt to ebitda
1.75
-
3.62
106.42%
2.91
19.68%
3.57
22.75%
3.82
7.06%
2.70
29.21%
2.32
14.09%
1.12
51.85%
2.50
123.37%
2.15
13.79%
2.50
16.21%
net income per share
3.53
-
4.76
34.62%
4.95
4.14%
5.12
3.36%
5.63
9.99%
7.31
29.75%
9.24
26.43%
16.10
74.23%
19.61
21.79%
17.73
9.57%
15.45
12.85%
operating cash flow per share
5.58
-
6.58
17.88%
7.07
7.40%
7.99
13.16%
10.14
26.82%
11.30
11.46%
12.43
10.01%
20.93
68.36%
24.22
15.71%
23.35
3.59%
21.66
7.22%
payables turnover
10.61
-
10.93
2.99%
10.68
2.27%
10.21
4.39%
7.68
24.84%
8.05
4.82%
7.14
11.22%
7.22
1.14%
6.62
8.38%
7.52
13.57%
9.62
28.00%
receivables turnover
6.74
-
6.83
1.31%
6.67
2.37%
5.99
10.08%
5.39
10.04%
5.89
9.21%
5.87
0.27%
5.61
4.45%
4.92
12.41%
5.43
10.44%
5.21
3.97%
research and ddevelopement to revenue
0.03
-
0.04
35.43%
0.04
0.27%
0.04
1.22%
0.04
2.78%
0.04
6.48%
0.04
1.09%
0.04
6.65%
0.04
2.18%
0.03
8.66%
0.03
4.74%
return on tangible assets
0.10
-
0.20
88.94%
0.21
7.31%
0.19
8.59%
0.15
20.63%
0.19
21.71%
0.20
8.05%
0.21
5.00%
0.24
12.19%
0.18
23.76%
0.16
12.34%
revenue per share
36.33
-
42.41
16.74%
42.55
0.32%
46.29
8.78%
52.96
14.41%
60.59
14.42%
63.85
5.39%
81.36
27.41%
99.52
22.32%
114.58
15.13%
110.46
3.60%
roe
0.08
-
0.09
22.05%
0.09
0.36%
0.09
1.45%
0.09
6.72%
0.11
21.64%
0.12
16.94%
0.18
48.33%
0.23
24.67%
0.16
31.47%
0.13
18.71%
roic
0.04
-
0.06
52.86%
0.05
18.62%
0.05
13.11%
0.04
8.92%
0.05
27.10%
0.06
22.05%
0.09
41.12%
0.09
4.62%
0.07
18.31%
0.06
13.00%
sales general and administrative to revenue
shareholders equity per share
46.78
-
51.60
10.30%
53.55
3.77%
54.56
1.88%
64.34
17.92%
68.62
6.66%
74.19
8.11%
87.14
17.46%
85.13
2.31%
112.33
31.95%
120.42
7.21%
stock based compensation to revenue
0.01
-
0.01
0.16%
0.01
6.27%
0.01
0.85%
0.01
4.05%
0.01
2.24%
0.01
4.64%
0.01
14.15%
0.01
3.58%
0.01
16.53%
0.01
5.10%
tangible asset value
-2.72B
-
-12.40B
356.30%
-10.19B
17.84%
-13.76B
34.98%
-16.56B
20.38%
-12.74B
23.08%
-10.05B
21.08%
-4.22B
58.03%
-61.91B
1,367.53%
-14.49B
76.60%
-13.85B
4.43%
tangible book value per share
-7.55
-
-31.15
312.87%
-25.56
17.94%
-34.85
36.32%
-41.93
20.32%
-31.69
24.42%
-25.13
20.69%
-10.65
57.61%
-157.14
1,374.98%
-36.96
76.48%
-35.69
3.45%
working capital
3.58B
-
997M
72.12%
1.55B
55.59%
2.17B
40.06%
2.44B
12.26%
4.42B
81.10%
5.66B
28.16%
11.65B
105.85%
6.73B
42.28%
8.25B
22.67%
10.58B
28.19%

All numbers in USD (except ratios and percentages)